throbber
3928
`
`J. Aifcd. Chern. 1998, 41, 3928-3939
`
`Articles
`
`Investigations of Neurotrophic Inhibitors of FK506 Binding Protein via Monte
`Carlo Simulations
`
`Nlichclle L. La1nb and Willia1n L. Jorgensen*
`
`Dcpartrnent of Chcn1ist1y, }"ale Unil'ersity, 1'le1v Haven, Connecticut 06520-8107
`
`Rccci1'cd JantJa1y 27, 1998
`
`The binding and solution-phase properties of six inhibitors of FK506 binding protein (FKBP 12)
`\Vere investigated using free energy perturbation techniques in Monte Carlo statistical
`n1echanics si1nulations. These noninununosuppressivc n1olccules are of current interest for
`their ncurotrophic activity \Vhen bound to FKBP 12 as \Vell as for their potential as building
`blocks for che1nical inducers of protein din1erization. H.clativc binding affinities \Vere con1puted
`and analyzed for ligands differing by a phenyl ring, an external phenyl or pyridyl substituent,
`and a pipecolyl or prolyl ring. Such results are, in general, valuable for inhibitor optiinization
`and, in the present case, bring into question sonic of the previously reported binding data.
`,.,
`
`Meo
`
`Introduction
`1'he a-ketoan1ide functionality of the innnunosup(cid:173)
`pressant natural product FI<S06 (Figure 1) is retained
`in 1nany of the highest affinity ligands that have been
`developed to inhibit the rota1nase (cis-trans peptidyl(cid:173)
`prolyl ison1erase, or PPlase) activity 1 of the FI<S06
`binding protein (FKBP12, MW= 12 kDa).2 Originally,
`interpretation of the crystal structure of Fl(506-
`FI<BP12 led to the belief that the a-ketoan1ide n1imics
`a t\visted-an1ide transition state of peptide bond iso1ner(cid:173)
`ization, although an endogenous substrate for FI<BP12
`had not been discovered. It \vas thought that blockage
`of the iso1nerase active site prevented n1odification of
`do\vnstrean1 proteins necessary for T~cell activation, and
`this \Vas the source of the observed in11nunosuppression.
`A sirnilar n1echanis1n had been proposed for the activity
`of the undecapeptide cyclosporin A (CsA). \Vhich inhibits
`the PP!ase cyclophilin, although neither the natural
`products nor the proteins are ho1nologous. Ho\vever,
`evidence that rota1nase inhibition \Vas not sufficient for
`itnn1unosuppression soon began to niount.3 Rapan1ycin
`(Figure I), another fungal 1nolecule structurally shnilar
`to Fl(506, inhibited FI<BP12 but appeared to influence
`a later stage of the '!'-cell cycle. Schreiber and co(cid:173)
`\vorkers4 1nade a significant contribution \Vith the syn(cid:173)
`thesis of a n1olecule \Vhich retained the Fl<BP 12 binding
`do1nain of FI<S06 and rapan1ycin (pyranose ring, a-ke(cid:173)
`toan1ide, pipccolate ester, and cyclohexyleth(en)yl groups).
`but in \Vhich the 1nacrocycle \Vas contracted. This
`n1olecule \Vas a rota1nase inhibitor but did not prevent
`1'-cell proliferation.
`It later becan1e clear that the fonnation of an in1n1u(cid:173)
`nosuppressant-hn1nunophilin co111plex results in a gain
`of function for the protein. 'fhe CsA-cyclophilin and
`FI<S06-Fl<BP12 pairs each present a recognition sur(cid:173)
`face to the calcium-dependent, serine/threonine phos(cid:173)
`phatase, calcincurin (CN).5 The FK50G-FKBP12 com(cid:173)
`plex binds at least 10 A fro1n the active site of CN and
`
`10
`
`0
`
`OH r
`" !
`
`w~
`
`FK-506
`
`0
`
`,,,
`
`10
`
`0
`
`0
`
`H
`
`f>
`
`' " I
`
`~
`r
`
`0
`
`0
`
`QH
`'¥
`
`"'
`
`0
`
`Rapamycin
`Figure 1. Structures and atotn nutnbering for the ilnn1uno(cid:173)
`suppressants FK506 and rapamycin.
`
`$0022-2623(98)00062-4 CCC: SIS.OD © 1998 Atnerican Cheinical Society
`Published on Web 09/19/1998
`
`Roxane Labs., Inc.
`Exhibit 1019
`Page 001
`
`

`

`f\1eurotrophic Inhibitors of FK506 Binding Protein
`
`Journal of A'1edicinal Che1nistiy, I 998, Vol. 4 I, No. 2 I 3929
`
`Table 1. Exprrl!nental Activities for Selected FKBP 12 Ligands
`
`con1pd
`
`stnicture
`
`rotarnase
`Ki. n?-.1
`
`neurite outgrowth
`EDs 0, nM"
`
`0.3
`
`250', 11 O'
`
`300
`
`130'. J 65'
`
`8.5
`
`52'
`
`53
`
`0.05
`
`2
`
`3
`
`4
`
`5
`
`6
`
`•1 Data on ncurltc outgrowth fro1n chick dorsal root ganglia reported In ref 2. Ii Data frmn Guilford Pharmaceuticals, refs 2 and 59.
`'"Data frmn S1nithKllnc Beecha1n, refs 13 and 16.
`
`1nust block binding of subsequent phosphorylated pro(cid:173)
`teins and thus the T-cell signaling path\\'ay.6·7 Reports
`of the association of ca\ciun1 channels containing -Leu(cid:173)
`Pro- sequences \Vi th both FI<BP 12 and CN are filling
`in another long-standing piece of the FI<BP12 puzzle,
`as these may represent endogenous "ligands" for FI<BP12
`1ni1nicked by FI<506.8 In contrast, rapa1nycin-FI<BP12
`interrupts a distinct signaling cascade through its
`interaction \Vith another protein, generally tenned
`FRAP (FI<BP-rapa1nycin-associated protein).9- 11 A
`crystallographic structure of this ternary co1nplcx con(cid:173)
`finns the recognition require1nents for rapainycin. 12 In
`both Fl< BP 12 ligands. it is the portion of the 1nacrocycle
`opposite the a-ketoan1idc-pipecolic acid 1noicty, the
`~effector" region, \vhich contacts calcineurin.
`As part of an effort to design lo\V 1nolecular \Veight
`PPiase inhibitors as scaffolds for the iln1nunosuppres·
`sive effector con1ponents, the crystal structure of
`1-FI<BP12 (Table l) \Vas solved at S1nithl(line Bcechan1
`in 1993.13 Figure 2 sho\vs the binding 1node revealed
`for the a-ketoa1nide and pipecolyl portion of 1. The keto
`carbonyl (04) contacts aro111atic hydrogens of Tyr26,
`Phe36, and Phe99 , and the pipecoline ring sits over 1'rp59,
`The 3-phcnylpropyl 1noiety binds in the solvent-exposed
`FK506-cyclohexyl groove of FKBP12 between lle 56 and
`
`Figure 2. Position of co1npound 1 (yello\v) in the aro1natic
`binding pocket of FKBP12 (green). 13 Molecular graphics hn(cid:173)
`ages \Vere produced using the fvlidasPlus soft\vare systen1 froin
`the Cosnputer Graphics Laboratory, University of California,
`San Francisco.r.o
`Tyr-82, and these residues for1n hydrogen bonds \Vith the
`ester (02) and a1nide (03) carbonyl oxygens of the
`ligand. 'fhe I-phenyl substituent interacts \Vith Phe46
`and the tertiary pentyl g1·oup of the inhibitor. A
`
`Roxane Labs., Inc.
`Exhibit 1019
`Page 002
`
`

`

`3930 Journal ofAiedicinal Che111ist1y, 1998, Vol. 41, f•lo. 21
`
`La1nb and Jorgensen
`
`Schc1ne 1
`
`FKBP·A
`
`FKBP + B
`
`FKBP · B
`
`--;
`ii Ge
`
`Figure 3. FKBP 12-bound confonnation of 1 (yello\v) overlaid
`\Vith that of FKSOG (red). 13·15
`
`con1parison of the bound conforn1ation of 1 and FI<SOG
`presented in Figure 3 detnonstrates that this n1ode is
`consistent \Vith that found in crystallographic structures
`ofFK506-FKBP12 and rapamycin-FKBPlZ.14.lS How(cid:173)
`ever, the ability to fonn hydrogen bonds to the Glu54
`carbonyl observed in co1nplexcs \Vith FI<S06 (C24-0I-l)
`and rapan1ycin (C28-0H) is not present in this ligand.
`Binding patterns sitnilar to those for 1 tnay be expected
`for compounds 2 and 3 (Table 1) as \Vell. 13·16 An ex(cid:173)
`cellent analysis of FI<BP12-ligand interactions, includ(cid:173)
`ing discussion of previously unpublished ato1nic struc(cid:173)
`tures, is included in a revie\v of protein-ligand recog(cid:173)
`nition 1notifs by Babine and Bender. 11
`An additional activity for rotarnase inhibitors of this
`class has expanded interest in these con1pounds beyond
`their potential in itn1nunosuppressant drug design. As
`revie\ved recently by I-Ia1nilton and Steiner, 2 FI<S06 has
`been sho\vn to induce the regeneration of damaged
`nerves in anhnal 1nodels of Parkinson's and Alzheiiner's
`diseases. Furthennore, the enriched concentration of
`Fl<BP12 in neurons has been associated \Vith nitric
`oxide synthesis, ncurotrans1nitter release, and neurite
`extension. Potent, nonhnn1unosuppressive FI<BP12
`ligands, such as V-10,367 18- 20 and GPl-1046 (6, Table
`
`o Ro
`MeO~o:
`
`Meo
`
`OMe
`
`I ...:
`N
`
`V-10,367
`
`1).21 - 23 are able to pro1note neuronal gro\vth in vitro and
`in vivo \Vithout the addition of exogenous gro\vth factors.
`They have a better therapeutic potential than gro\vth
`factors in that they arc orally bioavailable and able to
`cross the blood~brain barrier. The requireinent of
`binding to FI<BP12 for neuronal activity has also been
`de1nonstrated, but there is no linear relationship bc(cid:173)
`t\veen rota111ase inhibition and activity in neuronal
`cclls.2 FI<BP12 binding is apparently necessary but not
`sufficient for stirnulation of nerve gro\vth, suggesting
`
`that, as in T-cclls, the complex may 1nodify the function
`of an additional target.
`Another use of this class of Fl< BPI 2 ligands has also
`e111erged. The ability of the inununosuppressants 'to
`induce protein heterodin1erization and the kno\vledge
`of ligand n1odifications that prevent this association has
`been exploited for control of cellular signaling patlnvays,
`protein translocation, and gene activation.24·25 Target
`proteins are first artificially attached to the in1n1uno(cid:173)
`philins (FKBP12 or cyclophilin), CN, or FRAP. The
`ligands then1selves or synthetic ho1no- or hctcrodin1crs
`of FI<S06, CsA, or rapa1nycin then bring their protein
`partners together, resulting in the proxhnity of the tar(cid:173)
`get proteins and trans111ission of signa1.24 - 3o Recently,
`di111crs of 7 have been used to effect cellular apoptosis
`and to induce transcription, again \Vithout the hn1nu(cid:173)
`nosuppressive effecls of further binding to calcineurin. 31
`This technique of ~che1nically induced di1nerization",
`used \Vith s1nall, cell-per111eable n1oleculcs such as 7, is
`
`n
`0 t"'y0~oMo
`,,Co oQ-
`
`OMo
`
`"- I
`
`Linker
`
`7
`
`designed to have application in cellular gene therapy.
`Given the diverse biological applications of these
`a-ketoainidc ligands and that only slight differences in
`structure can have profound effects on activity, \Ve have
`used theoretical techniques to probe the binding of
`cornpounds 1-6 (Table l) at the aton1ic level, in both
`structural and energetic tcrn1s. Previous sitnulations
`of FI<BP12 have addressed the rotan1ase n1echanisn1
`applied to peptide substrates32 ·33 and the hnportance of
`Tyr82 in binding FI<506.3'1 Our current approach has
`focused on free energy perturbation (FEP) calculations,
`using Monte Carlo (MC) n1ethods rather than n1olecular
`dynan1ics (MD) for sa1npling. Con1puted relative free
`energies of binding, \Vhich are obtained fron1 shnula(cid:173)
`tions of the ligands in solution and bound to the protein,
`n1ay be con1pared \Vi th those obtained fro1n experitnen(cid:173)
`tal binding constants (Sche1ne 1), A veragcs of the
`co1nputed structures 1nay then be used to analyze the
`origin of the differences in binding affinities.
`'fhe MC n1cthod used here has been validated \Vi th a
`study of benzamidine inhibitors of trypsin35 and \Vas
`further applied to the analysis of orthogonal CsA(cid:173)
`cyclophilin pairs as co1nponents of a syste1n for chetni(cid:173)
`cally induced dhnerization,36
`'I'he present study is
`ain1cd at understanding factors that influence the
`binding of 1 and its analogues. In particular, the effects
`of ren1oval of the I-phenyl group, conversion of the
`3-phenyl to 3-(3-pyridyl), and ring contraction of the
`
`Roxane Labs., Inc.
`Exhibit 1019
`Page 003
`
`

`

`f1lcurotrophic Inhibitors of FK506 Binding Protein
`
`.Journal ofJ\-fcdicinal Chen1istry, 1998. Vol. 41, No. 21 3931
`
`pipecolyl ring to prolyl are exan1ined. There are dis~
`crcpancles in the binding data rron1 the t\VO experiinen(cid:173)
`tal sources, as indicated by the results for 2 and 3 in
`·rable I. Fron1 the crystal structure for 1 bound (Figure
`2), the pyridine nitrogen of 3 is anticipated to be solvent
`exposed. Thus, it \vould nonnally not be expected to
`favor the lo\ver dielectric cnviron1nent of a protein (E ~
`4) over that of bulk \Yater (E ~ 80),37 in contrast to the
`binding results fron1 Guilford Pharn1aceuticals. This
`\Vas pursued through co1nputations for the 2, 3 and 5,
`6 pairs.
`l-Ia1nilton and Steiner have also pointed out
`that 5 and 6 are the first exatnples ofprolyl cotnpounds
`that bind better than their pipecolyl analogues, but the
`high affinity is attributed only to "itnproved design" .2
`To investigate further, differences in free energies of
`binding \Vere co1nputed for t\vo pairs of pipecolyl and
`prolyl ligands. Co1npounds 2 and 5 represent the
`unusual case \Vith the prolyl ligand (5) as the better
`inhibitor. Co1npounds 1 and 4 represent the n1ore
`co1nn1on situation in \Vhich the presu1nably tnorc hy(cid:173)
`drophobic pipccolyl ligand (1) has higher affinity for
`FKBP12.
`
`Con1putational Details
`
`Paran1ctrization and Initial MC Sitnulations.
`'!'he crystal structure of l-FI<BP12 at 2.0 A resolution 13
`fron1 the Brookhaven Protein Data Bank38 (entry l fkg)
`\Va.s used as the starting point for the sin1ulations. The
`co1nputational protocol for the MC shnulations \Vas the
`san1e as in previous applications.35·36 The good precision
`that is obtainable for free energy changes \Vith this
`n1ethodology \Vas addressed extensively in ref 35. 'fhe
`MC sa1npling included variation of all bond angles and
`dihedrals of the ligand and protein side chains as \Vell
`as overall rotation and translation of the ligand and
`\Vater n1olecules. The protein backbone atoms \Vere held
`fixed in their crystallographic positions. 1'his 1nakes the
`i'v1C simulations 111ore rapid, and the approxhnation is
`justified for FI<BP 12. f{estricted backbone 1notion on
`the picosccond tiine scale has been noted for native
`FKBP 12, 39 and ligand binding further rigidifies the
`protein structure, as de1nonstratcd by the close rese111-
`blance an1ong ato111ic structures of FI<BPl 2 in nuinerous
`FI<BP12-ligand coniplexes. 17 To be consistent \Vith
`prior MD calculations on the FI(506-FKBPI2 syste111,40
`all 79 residues \Vithin 12 A of FI<506 in its cocrystal
`structure \Vith FI<BP12 14 \Vere sa1npled. This provided
`a greater nun1bcr of 1noving side chains than \vould be
`found in a 12 A region around 1.
`The OPLS united-ato111 force field 41 \Vith all-aton1
`aron1atic groups42 provided n1ost paran1eters for the
`protein: paran1eters for the inhibitors also ca1ne fro111
`this source and fron1 a previous MD study of FI<S06.43
`1\ listing of para1neters for the inhibitors is provided in
`the Supporting Inforn1ation. 'I'he torsional paran1eters
`for the an1ino acid residues \Vere derived fro1n fitting to
`torsional energy profiles obtained fro1n ab initio calcula(cid:173)
`tions \Vith the 6-31G" basis sct. 44 Any n1issing paran1-
`eters \Vere derived by fitting to i\1M2·15 energy profiles,
`\Vhich \Vere generated using Macromodel. 46 A scale
`factor of 112 \vas applied to all 1-4 nonbondcd interac(cid:173)
`tions. l·Iistidlnes 25, 87, and 94 arc kno\vn to be un(cid:173)
`protonated,47 and they \Vere designated as O-tauton1ers
`based on visual inspection. '1'his tauto1neric state has
`
`also been chosen in lvfD shnulations of Fl<BP 12-ligand
`con1plcxcs in solution.32·3·l.
`The unbound ligands and protcin--ligand cornplexes
`\Vere solvated \Vith 22 A spheres containing 1477 and
`939 TIP4P \\later 1nolecules, respectively. A half(cid:173)
`hannonic potential \Vi th a 1.5 kcal/11101 A2 force constant
`\Vas employed to prevent \Vaters fron1 1nigrating a\vay
`fron1 the cluster. A 9 A residue-based cutoff \Vas used
`for all nonbondcd interactions; if any pair or ato111s fro1n
`t\VO residues \Vas \Vithin this distance, all nonbonded
`interactions bct\veen the residues \Vere included in the
`energy evaluation. The list of nonbonded interactions
`\Vas updated every 2 x 105 configurations during the
`sin1ulations.
`All f\1.onte Carlo shnulations \Vere perforn1ed \Vith the
`MCPRO progra111.'18 An advantage of using internal
`coordinate MC n1ethods is the ability to focus sa1npling
`on specific regions and degrees of freedon1 of interest.
`Consequently, bond lengths \Vere fixed to their crystal
`structure values, and aro1natic rings \Vere treated as
`rigid units. To prevent inversion at sp3 centers such
`as a-carbons and to enforce planarity of sp 2 centers for
`n1ore efficient san1pllng, hnproper dihedral angles \Vere
`not varied except as noted belo\v. Othcr\visc, all bond
`angles and dihedrals in the 111oving portion of the syste1n
`\Vere san1pled.
`The l\1C siinulations \Vere carried out for 25 °C on
`Silicon Graphics \Vorkstations and on a cluster of
`personal con1putcrs using Pentiun1 p1·ocessors. It 111ay
`be noted that the cxperhncntal results con1e fro111 an
`assay for rotan1ase inhibition. 49 This \videly used
`procedure for 1neasuring FI<BP 12 binding affinities is
`usually perforn1ed son1e\vhat bclo\v roo1n ten1perature,
`e.g., near 10 °C. 13 The solvent \Vas first sa111pled for 1
`111illion (A1J configurations to re1nove any highly repul(cid:173)
`sive initial contacts \Vith the solutes. Then, 81\1! con(cid:173)
`figurations \Vere perfonned to equilibrate the 1-FI<BP 12
`con1plex.
`'I'he sa1ne protocol \Vas follo\ved for 1 in
`solution, beginning \Vith the bound confor1nation taken
`fro1n the 1-FI<BP 12 structure. During equilibration,
`the conforn1ation of the bound ligand ren1aincd sim(cid:173)
`ilar to the crystal conforn1ation; ho\vcvcr, partial in(cid:173)
`version of the pipecolyl ring occurred in solution to
`S\vltch it fron1 a chair to a half-chair conforrnation
`(Figure 4). In gas-phase opthnizations of ligand 1 \Vi th
`the present force field, the adopted ring confortnation
`is favored by 1.3 kcal/Jnol. 1'his is likely an artifact of
`using the AMBER C2-N-CH bending para1neters \Vi th
`00 = 118°, \Vhich 'vas not designed for a piperidine
`ring.50 The difference is expected to have little effect
`on the con1putcd free energy changes since the niutated
`phenyl rings are not in contact \Vith the pipecolyl ring
`or, in the case of the ring contraction, the chair con(cid:173)
`fonnation \Vas enforced (vi de infra).
`Free energy changes \Vere calculated during the MC
`sinnilations according to standard procedures of statis(cid:173)
`tical perturbation thcory.5!-53 The difference in free
`energy of binding (6.6.Gti) for 111olccule B relative to
`nlolecule A (Schen1e 1) 1nay be obtained fro1n transfor(cid:173)
`n1ations of the ligands in solution and bound to the
`protein according to eq 1:
`
`FEP Situulation Protocol for 1-2. This perturba-
`
`Roxane Labs., Inc.
`Exhibit 1019
`Page 004
`
`

`

`3032 Journal ofi\-fedicinal Chernistry, 1998, Vol. 41, /\'o. 21
`
`Larnb and Jorgensen
`
`Figure 4. Stereovie\vs of unbound ligand I. The initial geoinetry fro1n the 1-FKBP 12 crystal structure has the pipecolic ester
`substituent in an axial confonn~tion (top). Subsequent equilibration resulted in partial inversion of the ring {botto111).
`
`tion involved the rernoval of the !-phenyl ring of 1 to
`obtain 2. The aton1s of the phenyl group \Vere converted
`to "du1n1ny" ato1ns \Vithout charge or Lennard-Jones
`paran1eters, and the length of the bond connecting the
`substituent to the re1nainder of the ligand \Vas reduced
`to 0.65 A \Vith all other phenyl ring bonds reduced to
`0.35 A. The transforn1ation of 1-2 \Vas carried out in
`13 \Vindo\vs \Vith double-\vide san1pling, \Vhich yield 26
`free energy incre111ents. 51 A coupling paran1eter, J., \Vas
`e1nployed such that ), = 0 corresponds to the initial
`state, 1, and A= 1 corresponds to the final state, 2. 1'he
`first six \vindo\VS used ~). = ±0.025, \Vhile the ren1ain(cid:173)
`ing \Vinclo\VS used AA = ±0.050. All \Vere equilibrated
`\Vi th 2-4M configurations of sa1npling; the last config(cid:173)
`uration of the previous \Vindo\v \Vas used to start the
`next one. Averaging \Vas done in batches of 2 x 105
`configurations, \Vith data collected over a total of 4-7 lvf
`configurations in each \Vindo\v. For subsequent analy(cid:173)
`ses of hydrogen bonding, an additional 1 Iv! configura(cid:173)
`tions \Vere generated at the endpoints of the shnula(cid:173)
`tions.
`FEP Shnulation Protocol for 2----..3, 5-6. The next
`transforrnation addressed \Vas the conversion of a phen(cid:173)
`yl 1noiety to a 3-pyridyl ring.
`'fhis perturbation is
`straightfor\vard: the analogous perturbation of benzene
`to pyridine had been perforrned in the develop1nent of
`OPLS all-ato1n (OPLS-AA) paran1eters for pyridinc. 54
`As before, the standard phenyl ring structure \Vas
`transforrned to a pyridine geon1etry dctennined froin
`1nicro\vave expcrhnents. 51 A rnodel of 5 \Vas required
`prior to the conversion of fr-----6 and \Vas obtained by
`1napping a prolyl ring onto the final structure of 2 fro1n
`the 1-2 FEP calculation. In each shnulation, the prolyl
`or pipecolyl ring \Vas flexible. 'fhe perturbation protocol
`for these calculations \Vas slightly 111odified fro1n that
`
`used for 1-2 to take advantage of the acquisition of a
`nc\V parallel cotnputing syste1n \Vithin our laboratory.
`Seven double-\vide \Vindo\vs \Vere run in parallel, \Vi th
`4-BA1 configurations sa1nplcd during the equilibration
`phase and \Vith data collected over 4- l2M configura(cid:173)
`tions. A gas-phase FEP calculation \Vas also perfonned
`for 5-6 to allo\v estin1ation of the relative free energies
`of hydration of the t\VO ligands.
`FEP Sitnulation Protocol for 2-5, 1-4. In our
`experience, perturbations bet\veen different cyclic sys(cid:173)
`terns require 1nuch care to ilnplen1ent and can be
`particularly s\o\v to converge. The necessity of account(cid:173)
`ing for both changes in bonded and nonbonded interac(cid:173)
`tions \Vithin the ring as one aton1 disappears makes this
`a technically difficult perturbation. One \Vay to sin1plify
`the present calculations is to drive the ring fro1n one
`fixed six-n1en1bered ring confonnation to a fixed five-
`1nen1bered ring confonnation, "disappearing" the re(cid:173)
`n1aining atoin and sin1ultaneously reeling it in to\vard
`the others. For this rigid perturbation, changes in
`energy \Vi thin the ring need not be n1onitored, as these
`intraligand differences should be very sitnilar in each
`environn1ent (bound and unbound). Ho\vever, other
`possible confor1nations for the rings \vould not be taken
`into account, and the results could be sensitive to the
`path chosen.
`The silnulations for the unbound and bound trans(cid:173)
`fonnations \Vere started fron1 the final bound confonna(cid:173)
`tions of 2-FI<BP12 or 1-FI<BP 12 above \Vi th the chair
`conforn1ation for the pipecolyl ring. The final prolyl ring
`geo1netry \Vas obtained fron1 a gas-phase optitnization
`of the bound confonnation of 2 \Vith one ring ato1n
`converted to a du1n1ny atoin, as illustrated in Figure 5.
`Other than for the internal structures of the pipecolyl
`and prolyl rings, the sa1npling for the ligands included
`
`Roxane Labs., Inc.
`Exhibit 1019
`Page 005
`
`

`

`/\leurotrophic Inhibitors of FK506 Binding Protein
`
`Journal of Aledicinal Che1nist1y, 1998, Vol, 41. !\fa. 21 3933
`
`Figure 5. The initial and final ring confonnatlons of the 2-5 perturbation. The dununy at01n in 5 is noted Du.
`lS,0 r·-- • - 1-- ·•
`t "
`
`'.:I
`
`,------•----;--
`
`--i-
`
`. --- :::> - --
`
`_:: =~ -'---~~~-
`
`5.0
`
`,------~r-
`
`b
`
`all bond angles and dihedral angles, as before. Prior to
`the FEP calculation, the unbound ligands, 2 and 1, \Vere
`each resolvated and relaxed \Vi th 4.4M configurations
`of solvent-only san1pling, follo\ved by BM configurations
`of full equilibration. T\venty-one \Vindo\vs \Vere used
`to perfor1n the ring contraction in s1nall steps. Fortu(cid:173)
`nately. convergence \Vas rapidly achieved \Vithin the 4M
`configurations perfonned for both equilibration and
`averaging.
`
`Results and [)iscussion
`Effect of the 1-Phenyl Group, 1-2. Re1noval of
`the 1-phcnyl rnoiety fro1n I is a large perturbation but
`a co1nputationally attractive choice given the available
`struclural infonnation and the sizable difference in
`binding affinity (Table 1). The free energy change as a
`function of A fron1 the FEP calculations for the unbound
`and bound ligands proceeded sn1oothly (Figure 6a), \Vi th
`1'.G,q ~ 10.25 ± 0.31 kcal/mo! and 1'.GFKBP ~ 11.69 ±
`0.31 kcal/1110! (Table 2). 1'he resultant relative free
`energy of binding (t\i\Gb) of 1.4 kcal/mol obtained
`according to Sche1ne 1 is then in excellent agree1nent
`\Vith the experilnental observations of 1.4-1.6 kcal/Inol
`(Table 2).
`A con1parison of the averaged structures fro111 the
`sin1ulations \Vith the crystal structure yields several
`interesting observations. First, the average root-mean(cid:173)
`squarcd (rrns) deviations for non-hydrogen alo1ns be(cid:173)
`t\veen the structures sa1npled for the co1nplex of 1 and
`the crystal structure 13 \Ve1·e co1nputed. The average nns
`for the aton1s in the side chains that \Vere varied is 0.7
`A, and the average nns for the ligand 1 is 1.1 A. The
`corresponding 1naxhnu1n nns values for individual
`structures did not exceed 0.8 and 1.4 A, and the values
`at the end of the MC run \Vere 0.7 and 0.9 A. Thus, the
`MC san1pled .structures did not drift far fro1n the crystal
`structure, though sonic differences emerged. In the
`n-ketoan1ide region of the ligand, the crystallographic
`interaction of Oil \Vith an <:-hydrogen of Phe99 is not
`1naintained, but there is a frequent interaction of the
`S-hydrogcn \\1ith the atnide carbonyl oxygen (03). 'I'he
`hydrogen bonds to llc56 and Tyr82 are unaffected by the
`perturbation {Figure 2). Within con1pound 1, the I-phen(cid:173)
`yl and isopentyl groups ren1ain in contact. Ho\vevcr,
`the I-phenyl group n1oves a\vay so1ne fro1n Phe46 ; the
`shortest contact bet\veen aro1natic carbons increases
`fron1 4.5 A in the crystal structure to 5.6 A in the
`silnulation. In both the crystal structure and fro1n the
`
`-5.0 ~-~~--~-~-~--~-~-~-~~
`
`:::r
`
`'°
`
`-100
`
`:: r-~·
`
`~~~~=
`,.,; ''"'"''''" ~ "-,;
`;o;..
`--~"'
`&~-
`.,,"'-, .. ,,.
`w·
`,,lf·
`• .. ""
`
`··;;· .. ;,-,,,
`
`-15.0
`M
`
`·-
`
`OJ
`
`U ~ U
`
`U M ~ U
`
`U
`
`I•
`
`Figure 6. (a) Free energy profile for the transfonnation of
`1-2, \Vith error bars for each \Vindo\v sho\vn. (b) Profiles for
`2-3 and 5-6 (squares). (c) Profiles for 2-5 and 1-4
`(squares). Solid lines represent the unbound sinnliations, and
`the dashed lines result fron1 shnulations of FKBP12-ligand
`cotnplexes.
`
`'
`
`MC siinulations, the I-phenyl and isopcntyl groups pack
`\Vell into the hydrophobic pockel lhat is outlined by
`Phe46, Phe36, Jlc9o, Ile9 1, Tyr82 , and His87 (Figure 2). Loss
`of hyrdrophobic contacts upon ren1oval of the I-phenyl
`group is unfavorable for binding.
`'!'he sin1ulations also suggest that son1e specific
`contacts \Vith the I-phenyl group 1nay be relevant. As
`highlighted in Figure 7, the I-phenyl substituent 1nakes
`aryl CI-1· .. Q contacts \Vi th the backbone oxygen of Glu54
`and the Tyr82 hydroxyl oxygen, and it has an a1nino(cid:173)
`aro1natic interaction \Vith the c-nitrogen of I-lis87 . While
`the interactions of the I-phenyl group in 1 \Vith Tyr82
`and Glu 54 are found in n1ost of the structures analyzed,
`the interaction \Vith I-Iis87 occurs in only 29% of the
`analyzed structures. Average distances and frequencies
`
`Roxane Labs., Inc.
`Exhibit 1019
`Page 006
`
`

`

`3934 Journal ollvledicinal Chen1is1ry. 1998. Vol. 41, /\'o. 21
`
`La1nb and Jorgensen
`
`Table 2. Experin1enta\ Binding Free Energies, Calculated Free Energy Changes, and a Con1parison of Experimental and Calculated
`Relative Binding Free Energiesa
`
`exptJb
`
`ca led
`
`exptlc
`. - -
`"" c,,
`1.6, 1.4
`-0.4, 0.3
`-1.0
`-1.1
`0.7
`
`ca led
`MC,,
`1.4
`0.8
`0.9
`-1.7
`-1.9
`
`A-B
`1-2
`2-3
`5-6
`2-5
`1-4
`
`6.GA
`-10.6, -10.9
`-9.0, -9.5
`-10.1
`-9.0, -9.5
`-10.6, -10.9
`
`"'~
`-9.0, -9.5
`-9.4, -9.2
`-11.1
`-10.l
`-9.9
`
`f..,,GFKBP
`f..,,Gaq
`11.69 ± 0.31
`10.25 ± 0.31
`2.32 ± 0.08
`1.52 ± 0.09
`1.48 ± 0.07
`0.59 ± 0.08
`-10.07 ± 0.10
`-8.36 ± 0.09
`-8.76 ± 0.11
`-6.86 ± 0.11
`.~All free energies in kcal/11101. b Absolute binding free energies are derived front rota1nase inhibition data given In Table I, using 11C
`=/?Tin K; and T= 25 °C (298 K). c Relative binding free energies are only listed \Vhen experi1nenta\ data frmn the sa1ne source 1nay be
`con1pared.
`
`tion, 2-<~ and s--..6. Experhnental data fro1n Guilford
`Phannaceuticals suggests that 111odification to a pyridyl
`substituent i111proves binding of 3-phenylpropyl con1-
`pounds, although in one case this is contradicted by data
`obtained at Stnithl(linc Bcccharn (Table 2). Considering
`the ca. 4 kcal/n1ol n1orc favorable free energy of hydra(cid:173)
`tion of pyridine than of benzene54 and assun1ing that
`the pyridyl co111pounds bind in a n1anncr shnilar to 1
`in the solvent-exposed region of the binding pocket, the
`phenyl to pyridyl conversion \vould be expected to
`decrease binding affinity. Sin1ply put, a dipole is better
`solvated in a n1ediun1 \Vith a higher average dielectric
`constant.
`First, the salvation of the ligands \Vas addressed. 'fhe
`aqueous transforn1ation of z-..3 resulted in a free energy
`difference of 1.52 ± 0.09 kcal/n1ol, son1e\vhat larger than
`that for 5~6 (0.59 ± 0.08 kcal/mol). The gas-phase
`transfonnation of 5 to 6 yielded a free energy change of
`3.15 ± 0.04 kcalhnol, \Vhich cornbines for a net relative
`free energy of hydration of -2.6 kcal/1110! favoring 6.
`This is reasonable given the previous benzene to pyri(cid:173)
`dine results,5 4 and the larger, flexible ligand. Hydrogen
`bonds to \vater \Vere shnilar for both sets of ligands: as
`expected, the pyridyl nitrogen provides an additional
`acceptor site in 3 and 6 (Table 4).
`The free energy profiles for both pairs of unbound and
`bound perturbations are displayed in Figure 6b. They
`are again notably sn1ooth. As seen fro1n 1'able 2, the
`transfonnations in the protein are ca. 1 kcalhnol less
`favorable than those in solution, and the net result is a
`consistent preference for the phenylpropyl ligands. No
`direct protein contacts arc 1nade by the pyridyl nitrogen
`aton1; its interaction \Vith \vatcr is n1aintained ('fable
`4). For this hydrogen bond, the opthnal interaction
`energy is -6.2 kcal/Jnol, 51 n1uch stronger than an aryl
`Cl-1···0- or N- interaction.
`I·lo\vever, the pyridyl
`nitrogen does participate in a hydrogen-bonding net(cid:173)
`\vork \Vi th \Vater n1oleculcs and carbonyl oxygens in the
`protein backbone. As reflected in Figure 9, a t\vo-\vater
`bridge bet\veen the oxygen of Val55 and the nitrogen is
`found consistently in 6-FKBP12. In 3-FKBP12 the
`interaction is often 1nediated by three \Vater n1olccules,
`\Vith a fc\v structures in \Vhich one 1nolecule also bridges
`to the Gln53 carbonyl oxygen (Figure 9). The VaJ55
`oxygen has been noted previously as a consensus
`hydration site in FI<BP12-ligand con1plexes.57 Crystal(cid:173)
`lographic \Vatcrs from the 1-FI<BP12 structure 13 \Vere
`not explicitly included in the calculations, so it is
`gratifying that this interaction is established during the
`MC shnulations. Water surrounding the ligand in the
`binding pocket can also bridge longer distances: for
`exa1nple, in 6-Fl<BP12, four 111oleculcs link the hy-
`
`Figure 7. Intennolecular aryl CH·"N, 0 contacts \vith His87
`Tyr'2 , and Glu 54 1nade in 1-FKBP12 that are lost on trans(cid:173)
`fonnation to 2-FKBP 12. One representative configuration
`frmn the Monte Carlo shnulation is illustrated.
`
`,
`
`of occurrence of these and other key interactions be(cid:173)
`t\vccn the ligands and FI<BP12 are sun1n1arized in
`1'able 3. Such aryl interactions are con1111only observed
`in protein crystal structures, and their orientational
`distributions have been analyzed.55,56 To provide a
`sense of the strength of the aryl CH···X interactions
`\Vith the OPLS-AA force field, gas-phase opthnizations
`for co1nplexes of benzene \Vith phenol. hnidazole, N-
`111cthylacctan1ide, and \Vater yielded the interaction
`energies sho\vn in Figure 8. With the hydrogen bonds
`constrained to be linear, the intrinsic interaction ener(cid:173)
`gies arc in the 1-2 kcalhnol range.
`In both cornplexes, the 3-phenylpropyl n1oicty rcn1ains
`in the FJ(506-cyclohexyl region of FI<BP 12, and there
`is usually a \Vater 1110\ccule \Vell-positioned on the face
`of one or both phenyl rings in 1 (Figure 7). For
`reference, in the gas phase, the opthnal JT hydrogen bond
`bet\veen benzene and a \Vater n10\ecule has an interac(cid:173)
`tion energy of ca. -3.5 kcalhnol.42 An arornatic hydro(cid:173)
`gen of the 3-phenylpropyl group often interacts \Vi th the
`carbonyl oxygen of Val55 in 1-FI<BP12; this contact is
`shorter and 1nore frequent in 2-FI<BP12 (Table 3). In
`addition, \Vhile the 1-phcnyl ring no longer interacts
`\Vith the Glu5'1 backbone carbonyl oxygen \Vhen the
`transfonnation to 2 is con1plete, the 3-phenyl ring shifts
`to pick up this contact. Considering these observations,
`it is likely that the inajor contribution to the \Veaker
`binding for 2 than 1 is the overall reduction in hydro(cid:173)
`phobic interactions and, possibly, the specific loss of the
`aryl CJ-I•"O, N contacts bet\veen the 1-phenyl group and
`'fyr82 and His

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket